Clinical Trial Update: Safety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) [EARLY_Phase 1]

View source ↗

Summary

This early-phase Phase 1 trial evaluates the safety and preliminary efficacy of combining LC-K76 with an anti-PD-1 therapy in patients with metastatic castratio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• Anti-PD-1 therapy
• LC-K76 (LC-K76)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: mCRPC | EARLY_Phase 1 | Status: NOT_YET_RECRUITING